CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Planned sale SVP, Head of Finance & Admin. sold 13,000 shares at $24.34 ($316,420)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 1,714,285 shares at $17.50 ($29,999,988)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 4 Planned sale CEO & President sold 269,719 shares at an average $18.66 ($5,032,915)
- 4 Planned sale Chief Scientific Officer sold 87,779 shares at an average $18.57 ($1,629,985)
- 4 Planned sale Chief Business Officer sold 31,900 shares at an average $16.59 ($529,194)
- 4 Planned sale SVP, Head of Finance & Admin. sold 13,000 shares at $18.81 ($244,530)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-3MEF Other S-3MEF
- 8-K Event Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 26 of 40 · 796 filings